Belgium
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
3.81 |
Jan. 14, 2025 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
3.43 |
Jan. 14, 2025 | USD 13.71 | -0.44% |
|
Belgium |
|
3 |
1.64 |
Jan. 14, 2025 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
0.57 |
Jan. 14, 2025 | USD 19.81 | 0.71% |
|
Belgium |
|
5 |
0.55 |
Jan. 14, 2025 | USD 24.20 | -0.41% |
|
Belgium |
The Biotechnology company in Belgium with the highest Price to Book Ratio (P/B) is UCB SA (Brussels Stock Exchange: UCB.BR) at 3.81.
The Biotechnology company in Belgium with the lowest Price to Book Ratio (P/B) is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at 0.55.
The top 10 Biotechnology companies in Belgium by Price to Book Ratio (P/B) are UCB SA, Ion Beam Applications SA, Azelis Group NV, Tessenderlo Group NV and Galapagos NV.
The bottom 10 Biotechnology companies in Belgium by Price to Book Ratio (P/B) are Galapagos NV, Tessenderlo Group NV, Azelis Group NV, Ion Beam Applications SA and UCB SA.